ClinicalTrials.gg
RecruitingNCT06879431Updated May 31, 2025

Preoperative Sleep Intervention on Postoperative Delirium in School-aged Children Undergoing Congenital Heart Surgery

An interventional study of cognitive-behavioral intervention in Delirium - Postoperative, Sleep Problems and Congenital Heart Disease (CHD), sponsored by Yan Fuxia. Recruiting at 1 site in China. Open to participants aged 6 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-05-31.

Sponsored by Yan Fuxia · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
544
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 185 studies in Emergence Delirium with a site in China — 64 open to participants now, 65 under way, 1 of them phase 3. Emergence Delirium · China.

Planned enrollment
23rd of 111
544 · median 225
Started
2025
with 20 others
No phase
70 of 185
29 open now
Primary completion
2025-12
later than 17 of 64 live
Registered
133rd of 185
by date

Among the 185 studies in Emergence Delirium with a site in China, this one is the 23rd largest by planned enrollment of the 111 interventional ones that give a count, is one of 21 that started in 2025, is one of 70 with no phase, reaches primary completion later than 17 of the 64 other live ones, and was the 133rd registered.

Emergence Delirium

753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.

Browse Emergence Delirium studies →

Open to participants now

64 of the 185 studies in Emergence Delirium with a site in China are open now. Recruiting first, the newest first:

58 more — sign in →

All 64 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.

This study: 6 Years to 12 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 185 studies in Emergence Delirium with a site in China, or all of them as a file.
02

Study summary

This is a multicenter, randomized, controlled clinical trial aimed to determine whether preoperative sleep interventions could reduce the incidence of adverse outcomes, such as postoperative delirium, in sleep-disordered school-aged children undergoing congenital heart surgery. The study will include infants and toddlers undergoing elective cardiac surgery with sleep disorders, assessed by the Children's Sleep Habits Questionnaire (CSHQ). All participants will be randomly assigned to the intervention group and Controll group in a 1:1 ratio. The intervention group received a short intensive cognitive-behavioral intervention 7-14 days before surgery, and no intervention was imposed on the control group. The results of this study will provide suggestions for the prevention of delirium after cardiac surgery.

Read the detailed description

The study will be carried out in Fuwai Hospital, Chinese Academy of Medical Sciences, Anzhen Hospital Affiliated to Capital Medical University, Fuwai Central China Cardiovascular Hospital, Fuwai Cardiovascular Hospital of Yunnan Province, and Children's Hospital Affiliated to Capital Institute of Pediatrics.

The research process is as follows: Conduct a routine assessment of sleep disorders for the children visiting the outpatient clinic. The guardians fill out the online Children's Sleep Habits Questionnaire. Fully inform the children with sleep disorders and their guardians of all the contents and procedures of this trial. After obtaining informed consent and signing the informed consent form, conduct a further assessment on the children to determine whether they meet the inclusion and exclusion criteria. All enrolled children and their guardians will receive preoperative education for congenital heart disease in the outpatient clinic. After stratification by research center, the random block is set to 4 - 6, the R will be used to randomly assign subjects to the experimental group and the control group at a 1:1 ratio. After randomization, the parents of children in the experimental group register for a WeChat mini-program, and the children receive cognitive-behavioral interventions every day before surgery. Guardians need to strictly implement and cooperate with researchers through phone calls (during the waiting period for admission) or face-to-face communication (during the preoperative hospitalization period). The control group does not receive any intervention and follows routine clinical practice. To better control the quality of interventions for children aged 6 - 12 in the experimental group, the daily implementation status of parents is counted for the degree of implementation (0 - 100%) in the WeChat mini-program. Guardians record the children's daily sleep diaries (online questionnaires) before surgery. The day before surgery, parents fill out the online Children's Sleep Habits Questionnaire again and compare the scores with the baseline scores. After admission, children wear actigraphs until the day of surgery and until discharge after surgery to automatically record sleep-related information. After the children are enrolled in the study, relevant researchers will supervise the implementation of cognitive-behavioral interventions for the children once a day before surgery to ensure that the actigraph device functions properly during hospitalization and remind guardians to record electronic sleep diaries until the night before surgery. Follow-up will be conducted within 7 days after surgery or before discharge to evaluate outcomes such as delirium and pain. The primary outcome is the incidence of postoperative delirium, and secondary outcomes include postoperative sleep quality, pain score, perioperative organ injury (including AKI, acute lung injury, and postoperative liver dysfunction), clinical recovery and prognosis.

03

Conditions studied

  • Delirium - Postoperative
  • Sleep Problems
  • Congenital Heart Disease (CHD)
04

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 0-36 months
  2. Scheduled to undergo elective corrective surgery for congenital heart disease under cardiopulmonary bypass.
  3. Sleep disorder assessed by Children's Sleep Habits Questionnaire (CSHQ) (CSHQ score >48)

Exclusion criteria

Exclusion Criteria:

  1. Preoperative use of sleep therapy-related medications
  2. The risk adjustment in congenital heart surgery-1 (RACHS-1 classification) ≥4
  3. History of preoperative cardiac assist device, mechanical ventilation support, or asphyxia rescue
  4. Emergency surgery or preoperative ICU admission
  5. History of neurodevelopmental disorders such as autism spectrum disorder, attention deficit hyperactivity disorder, or psychiatric disorders such as depression
  6. Combined severe hepatic and renal dysfunction
  7. Combination of non-cardiac malformations (adenoid hypertrophy, tracheobronchial stenosis, polysplenism, anaplastic syndrome, Down syndrome, DiGeoge syndrome, diabetes mellitus, reproductive system abnormalities, anal atresia and Williams syndrome, eye disorders)
  8. History of preoperative cerebral ischemia and hypoxia
  9. Concurrent participation in other clinical trials
  10. Refusal of the family to sign the form or poor compliance by the child
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
544 participants (estimated)

Study arms

  • Experimental
    CBT group

    The intervention group received a short intensive cognitive-behavioral therapy (CBT) intervention 7-14 days before surgery

    Behavioral: cognitive-behavioral intervention

  • No intervention
    control group

    no intervention was imposed on the control group

Interventions

  • Behavioralcognitive-behavioral intervention

    After enrollment in the experimental group, the guardians were asked to fill out a sleep diary every day before surgery to self-report the children's sleep, and to wear a somatic movement recorder to monitor sleep (non-dominant arm) (wGT3x-BT accelerometer, ActiGraph) during the preoperative hospitalization period, except during surgery, and then to wear it to record the sleep-related parameters until 7 days after surgery or before discharge from the hospital.Preoperative daily cognitive-behavioral interventions (developmental trials were guided with WeChat applets), including cognitive change, sleep hygiene, sleep restriction, stimulus control, and relaxation training

06

What researchers measure

Primary outcomes

  1. The incidence of postoperative delirium

    Time frame: Postoperative 7 days

Secondary outcomes

  1. Mechanistic endpoint: Concentration of plasma S-100β protein

    S-100β protein was used as a surrogate biomarker for the disruption of the blood-brain barrier.

    Time frame: Before surgery, at the end of surgery and 24 hours after surgery

  2. Pain defined by the Wong-Baker faces pain scale (revision)

    The Faces Pain Scale-Revised (FPS-R) requires patients to rate their overall pain intensity on a scale from 0 (no pain) to 10 (worst possible pain). Simultaneously, the FPS-R provides six cartoon illustrations of facial expressions (ranging from smiling, sad, to agonized crying) to visually represent the pain levels corresponding to different score ranges. This design aligns with children's concrete thinking characteristics. During assessment, the child simply points to the numerical rating or cartoon face that best matches their perceived pain intensity, making it particularly suitable for children aged 4 to 12 years.

    Time frame: Postoperative 7 days

  3. The incidence of postoperative Acute kidney injury

    Time frame: Within postoperative 7 days

  4. The incidence of Pulmonary complication

    Time frame: Postoperative 7 days

  5. The incidence of postoperative Liver dysfunction

    Time frame: Postoperative 7 days

  6. Concentration of intestinal fatty acid binding protein (I-FABP)

    one of markers of intestinal injury

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  7. Concentration of zonulin

    One of markers of intestinal injury

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  8. Concentration of lipopolysaccharide (LPS)

    one of markers of intestinal injury

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  9. Concentration of lipopolysaccharide binding protein (LBP)

    One of markers of intestinal injury

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  10. Types and dosages of drugs used for postoperative sedation and analgesia

    Time frame: Postoperative 7 days or before discharge

  11. Concentration of IL-6

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  12. Concentration of TNF-α

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  13. Concentration of IL-1β

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  14. Concentration of IFN-γ

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  15. Concentration of IL-17

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  16. Concentration of C-reactive protein

    Time frame: before surgery, at the end of surgery and 24 hours after surgery

  17. The duration of postoperative mechanical ventilation

    Time frame: From the end of the surgery to the removal of the tracheal intubation,up to 30days

  18. The length of intensive care unit stay

    The time spent in the intensive care unit.

    Time frame: From the end of the surgery to discharge from the hospital,up to 30 days

  19. The length of postoperative hospital stay

    Time frame: From the end of the surgery to the day of discharge from the hospital,up to 30 days

  20. Average daily cost

    total hospitalization cost divided by total length of stay

    Time frame: admission to discharge, up to 30days

Other outcomes

  1. Long-term Sleep quality score

    guardians scored sleep quality 1-5 using a sleep diary

    Time frame: 30 days, six months, 1 year postoperatively

  2. Strengths and Difficulties Questionnaire Score

    The Strengths and Difficulties Questionnaire (SDQ) consists of 25 items (0-50 scores) assessing five main domains: emotional symptoms, behavioral problems, oppositional behaviors, peer relationship problems, and social competence. These dimensions allow researchers to get a comprehensive picture of a child's emotional and behavioral status, with higher scores being more severe. Guardians will be required to complete the electronic SDQ Parent Version Questionnaire at 6 months postoperatively and 1 year postoperatively

    Time frame: 6 months and 1 year after surgery

  3. Readmission rate

    the rate at which a patient is readmitted to the hospital for the same or a different health problem within 30 days/six months/1 year after discharge

    Time frame: 30 days,6 months,1 year after discharge

  4. 1-year mortality

    the death rate of 1 year after surgery

    Time frame: 1 year after surgery

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Dec 2025, 8 months after the start.

Of 186 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 8 months is below that.

Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 7 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 25, 2025
First posted
Mar 17, 2025
StartActual
Apr 28, 2025
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2026
Last update
May 31, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 31, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06879431
Lead sponsor
Yan Fuxia
Responsible party
Yan Fuxia (principal investigator, Chinese Academy of Medical Sciences, Fuwai Hospital) — Sponsor-investigator
First posted
Mar 17, 2025
Start date
Apr 28, 2025
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
May 31, 2025

Study contacts

Fuxia Yan
Contact
yanfuxia@sina.com
010 88396628
Fuxia Yan
principal investigator · Chinese Academy of Medical Sciences, Fuwai Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion